Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

SL Hauser; S L Hauser; K Selmaj; A Traboulsee; JS Wolinsky; J S Wolinsky; DL Arnold; D L Arnold; G Klingelschmitt; D Masterman; P Fontoura; S Belachew; P Chin; N Mairon; A Bar-Or; H Garren; L Kappos; I OPERA; II OPERA; Irina Elovaara; G Comi; G Giovannoni; HP Hartung; H P Hartung; B Hemmer; F Lublin; X Montalban; KW Rammohan; K W Rammohan

doi:10.1056/NEJMoa1601277

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

SL Hauser, S L Hauser, K Selmaj, A Traboulsee, JS Wolinsky, J S Wolinsky, DL Arnold, D L Arnold, G Klingelschmitt, D Masterman, P Fontoura, S Belachew, P Chin, N Mairon, A Bar-Or, H Garren, L Kappos, I OPERA, II OPERA, Irina ElovaaraG Comi, G Giovannoni, HP Hartung, H P Hartung, B Hemmer, F Lublin, X Montalban, KW Rammohan, K W Rammohan

Research output: Contribution to journal › Article › Scientific › peer-review

1426 Citations (Scopus)

Original language	English
Pages (from-to)	221-234
Journal	The New England Journal of Medicine
Volume	376
Issue number	3
DOIs	https://doi.org/10.1056/NEJMoa1601277
Publication status	Published - 2017
Publication type	A1 Journal article-refereed

Publication forum classification

Publication forum level 3

Access to Document

10.1056/NEJMoa1601277

http://urn.fi/URN:NBN:fi:tuni-202002212278

Cite this

Hauser, SL., Hauser, S. L., Selmaj, K., Traboulsee, A., Wolinsky, JS., Wolinsky, J. S., Arnold, DL., Arnold, D. L., Klingelschmitt, G., Masterman, D., Fontoura, P., Belachew, S., Chin, P., Mairon, N., Bar-Or, A., Garren, H., Kappos, L., OPERA, I., OPERA, II., ... Rammohan, K. W. (2017). Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis. The New England Journal of Medicine, 376(3), 221-234. https://doi.org/10.1056/NEJMoa1601277

@article{5b30a754d7c24efd96d5d354972e984c,

title = "Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis",

author = "SL Hauser and Hauser, {S L} and K Selmaj and A Traboulsee and JS Wolinsky and Wolinsky, {J S} and DL Arnold and Arnold, {D L} and G Klingelschmitt and D Masterman and P Fontoura and S Belachew and P Chin and N Mairon and A Bar-Or and H Garren and L Kappos and I OPERA and II OPERA and Irina Elovaara and G Comi and G Giovannoni and HP Hartung and Hartung, {H P} and B Hemmer and F Lublin and X Montalban and KW Rammohan and Rammohan, {K W}",

year = "2017",

doi = "10.1056/NEJMoa1601277",

language = "English",

volume = "376",

pages = "221--234",

journal = "The New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachusetts Medical Society",

number = "3",

}

Hauser, SL, Hauser, SL, Selmaj, K, Traboulsee, A, Wolinsky, JS, Wolinsky, JS, Arnold, DL, Arnold, DL, Klingelschmitt, G, Masterman, D, Fontoura, P, Belachew, S, Chin, P, Mairon, N, Bar-Or, A, Garren, H, Kappos, L, OPERA, I, OPERA, II, Elovaara, I, Comi, G, Giovannoni, G, Hartung, HP, Hartung, HP, Hemmer, B, Lublin, F, Montalban, X, Rammohan, KW & Rammohan, KW 2017, 'Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis', The New England Journal of Medicine, vol. 376, no. 3, pp. 221-234. https://doi.org/10.1056/NEJMoa1601277

TY - JOUR

T1 - Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

AU - Hauser, SL

AU - Hauser, S L

AU - Selmaj, K

AU - Traboulsee, A

AU - Wolinsky, JS

AU - Wolinsky, J S

AU - Arnold, DL

AU - Arnold, D L

AU - Klingelschmitt, G

AU - Masterman, D

AU - Fontoura, P

AU - Belachew, S

AU - Chin, P

AU - Mairon, N

AU - Bar-Or, A

AU - Garren, H

AU - Kappos, L

AU - OPERA, I

AU - OPERA, II

AU - Elovaara, Irina

AU - Comi, G

AU - Giovannoni, G

AU - Hartung, HP

AU - Hartung, H P

AU - Hemmer, B

AU - Lublin, F

AU - Montalban, X

AU - Rammohan, KW

AU - Rammohan, K W

PY - 2017

Y1 - 2017

U2 - 10.1056/NEJMoa1601277

DO - 10.1056/NEJMoa1601277

M3 - Article

SN - 0028-4793

VL - 376

SP - 221

EP - 234

JO - The New England Journal of Medicine

JF - The New England Journal of Medicine

IS - 3

ER -